Volume 10, Number 6—June 2004
Dispatch
Antibacterial Resistance, Wayampis Amerindians, French Guyana
Karine Grenet*, Didier Guillemot†, Vincent Jarlier‡, Brigitte Moreau§, Stéphane Dubourdieu*, Raymond Ruimy*, Laurence Armand-Lefevre*, Pierre Bau*, and Antoine Andremont*
Table 2
Prevalence of carriage of gram-negative bacteria resistant to various antibacterial agents in the predominant and the subdominant fecal flora of the 93 study participantsa
| Antibacterial agent | Predominant florab |
Subdominant flora |
||||||
|---|---|---|---|---|---|---|---|---|
| Escherichia coli (%) | Klebsiella sp. (%) | Enterobacter sp. (%) | Other (%) | Any (%) | Lactose positive (%) | Lactose negative (%) | Any (%) | |
| Ampicillin |
51 (55) |
19 (21) |
5 (5) |
2 (2) |
77 (83) |
89 (96) |
31 (33) |
93 (100) |
| Ceftazidime |
0 |
0 |
0 |
0 |
0 |
3c (4) |
11d (12) |
14 (15) |
| Nalidixic acid |
0 |
0 |
0 |
0 |
0 |
7e (8) |
0 |
7 (8) |
| Pefloxacine |
0 |
0 |
0 |
0 |
0 |
ND |
ND |
ND |
| Streptomycin |
42 (45) |
2 (2) |
0 |
0 |
44 (47) |
83 (90) |
19 (21) |
86 (93) |
| Kanamycin |
5 (5) |
0 |
0 |
0 |
5 (5) |
45 (49) |
4 (5) |
47 (51) |
| Tetracycline |
59 (63) |
14 (15) |
0 |
2 (2) |
75 (81) |
86 (93) |
25 (27) |
86 (93) |
| Cotrimoxazole |
27 (29) |
0 |
0 |
0 |
27 (29) |
ND |
ND |
ND |
| Chloramphenicol | 22 (24) | 0 | 0 | 0 | 22 (24) | 48 (52) | 27 (29) | 60 (67) |
aAccounting for 23.9% (93 of 388) of the global population of the villages studied and not significantly different from it for male/female ratio or age distribution.
bBacteria with intermediate susceptibility were categorized as resistant.
cExtended spectrum β-lactamase E. coli.
dAcinetobacter baumanni: 9 (all with the same susceptibility pattern including susceptibility to ureidopenicillins, third generation cephalosporins, aminoglycosides, and quinolones) and Ochrobactrum spp. (identified by 16s RNA genes sequencing): 2.
eE. coli.
